These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 24338700

  • 21. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
    Chen YW, Chiu YW, Chen CY, Chuang SK.
    Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain.
    Dessie SG, Von Bargen E, Hacker MR, Haviland MJ, Elkadry E.
    Am J Obstet Gynecol; 2019 Nov; 221(5):517.e1-517.e9. PubMed ID: 31254522
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Botulinum toxin infiltrations versus local anaesthetic infiltrations in pelvic floor myofascial pain: Multicentre, randomized, double-blind study.
    Levesque A, Ploteau S, Michel F, Siproudhis L, Bautrant E, Eggermont J, Rabischong B, Volteau C, Perrouin-Verbe MA, Labat JJ.
    Ann Phys Rehabil Med; 2021 Jan; 64(1):101354. PubMed ID: 31981833
    [Abstract] [Full Text] [Related]

  • 27. Botulinum toxin type A and myofascial pain syndrome: a retrospective study of 301 patients.
    Avendaño-Coy J, Gómez-Soriano J, Valencia M, Estrada J, Leal F, Ruiz-Campa R.
    J Back Musculoskelet Rehabil; 2014 Jan; 27(4):485-92. PubMed ID: 24867895
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effectiveness of Botulinum Toxin for Treatment of Symptomatic Pelvic Floor Myofascial Pain in Women: A Systematic Review and Meta-analysis.
    Meister MR, Brubaker A, Sutcliffe S, Lowder JL.
    Female Pelvic Med Reconstr Surg; 2021 Jan 01; 27(1):e152-e160. PubMed ID: 32301801
    [Abstract] [Full Text] [Related]

  • 33. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.
    Graboski CL, Gray DS, Burnham RS.
    Pain; 2005 Nov 01; 118(1-2):170-5. PubMed ID: 16202527
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA, Lokhande N, Habbu SG, Sewane S, Dongare S, Goyal N.
    Indian J Dent Res; 2017 Nov 01; 28(5):493-497. PubMed ID: 29072209
    [Abstract] [Full Text] [Related]

  • 35. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
    Baker JS, Nolan PJ.
    J Am Dent Assoc; 2017 Jan 01; 148(1):33-39. PubMed ID: 28314397
    [Abstract] [Full Text] [Related]

  • 36. [Use of botulinum toxin the the treatment of muscle pain].
    Benecke R, Dressler D, Kunesch E, Probst T.
    Schmerz; 2003 Dec 01; 17(6):450-8. PubMed ID: 14648320
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Botulinum toxin in the management of temporomandibular disorders: a systematic review.
    Thambar S, Kulkarni S, Armstrong S, Nikolarakos D.
    Br J Oral Maxillofac Surg; 2020 Jun 01; 58(5):508-519. PubMed ID: 32143934
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.